Skip to content
< Back to blog

Devyser and Dahui Biotech sign distribution deal for the Chinese market


News | October 2, 2017

Devyser, pioneer in diagnostic kits for complex DNA testing, and Dahui Biotech, major supplier of biotech and diagnostic products, announce today the signing of a new partnership for distribution of Devyser’s market leading test kits for rapid prenatal aneuploidy diagnostics in China.

Ulf Klangby, CEO and founding partner of Devyser, says,

“There is an increasing demand for our prenatal diagnostic products in China. Dahui Biotech’s established distribution and service organization reaches genetic laboratories across China. This, together with their extensive expertise in prenatal diagnostic products, makes Dahui Biotech the ideal distribution partner for our products.”

Cheng Zhang, CEO of Dahui Biotech, comments,

“We are excited to offer Devyser’s popular prenatal diagnostic products in China. The products are already in use at several reference laboratories in China and are in demand because of their high quality. They help laboratories speed up analysis time from weeks to hours, thereby improving throughput and reducing parental anxiety through shorter waiting time. This is fully in line with our commitment to always offer the best available technology to our customers.”

Contact an expert at Devyser

If you have a question, feel free to send us a message. One of our team members will get in touch with you as soon as possible.

Contact us